VAC4EU is a pan-European research network for post-authorisation vaccine safety and benefit monitoring, specialised in the collaborative generation of real-world evidence on coverage, safety, and efficacy of vaccines in Europe.

TBVI and EVI are both European non-profit Product Development Partnerships (PDPs) that support global efforts the development of effective and affordable vaccines, with TBVI focused on tuberculosis and EVI focused on the prevention of diseases of poverty and emerging infectious diseases.

With this new collaboration TBVI, EVI and VAC4EU will look for opportunities for collaborative fundraising efforts, knowledge sharing and exploring possible opportunities to co-create and collaborate on topics of mutual interest.